Article Test

Home  >  Medical Research Archives  >  Issue 149  > COVID-19, Geopolitics, and the Reform of European Pharmaceutical Law: Accelerating Enhanced Medicines Care for Europe?
Published in the Medical Research Archives
Jan 2024 Issue

COVID-19, Geopolitics, and the Reform of European Pharmaceutical Law: Accelerating Enhanced Medicines Care for Europe?

Published on Jan 30, 2024

DOI 

Abstract

 

Given the COVID-19 pandemic and intensified geopolitical disruptions, the European Commission, seeking to govern pharmaceutical supply, faced various problems from within and outside the European Union. The authority subsequently submitted far-reaching proposals to revise, amend, and repeal the European Union’s pharmaceutical law. It is against this backdrop that the article examines the different policy impacts on the new pharmaceutical legislation and makes a brief forecast about the extent to which the draft measures, should they come into force as proposed, will contribute to better medicines care in the future. In doing so, the analysis concludes that COVID-19 was a mere accelerator and not the original trigger of most legislative changes. Furthermore, the article argues that, although problems have been identified correctly, some of the approaches to solving them are entrenched in ineffective paths.

Author info

Kristine Plank

Have an article to submit?

Submission Guidelines

Submit a manuscript

Become a member

Call for papers

Have a manuscript to publish in the society's journal?